Transcriptomic associations of a pre-specified 468-gene redox and xenobiotic-metabolism panel across five neurological disorders, with a published-variant inventory

This article has 0 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Five neurological disorders—Alzheimer’s disease (AD), autism spectrum disorder (ASD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS)—have distinct clinical and pathological features. I performed independent within-disease random-effects meta-analyses of public transcriptomic cohorts using an immutable 468-gene redox, metal-homeostasis, xenobiotic-metabolism, and barrier panel, and separately inventoried published variants in panel genes for AD, PD and ASD. AD brain, ALS spinal cord/motor neuron, and MS white matter showed disease-specific patterns; in bulk PD substantia nigra two external cohorts supported the high-confidence set in direction and rank but not in per-gene significance. Across the four adult neurodegenerative analyses, 53 genes met the locked high-confidence rule in at least two analyses (Online Resource 3). Seven genes—AKR1C3, CBS, CP, FTL, HMOX1, PINK1, and SLC40A1—met that rule in at least three; CBS was up in AD and PD and down in MS, so the rule does not imply uniform direction or a shared mechanism. HMOX1 was positive in several adult analyses; GSS and GSR transcripts were lower in AD and PD. Adult ASD postmortem brain was a robust FDR null (1 of 392 genes analyzable in at least two cohorts; that gene did not meet the high-confidence rule). Cell-type datasets in MS and PD supply compartment context only. A competitive gene-label permutation test did not show that the 468-gene panel out-enriched power-matched random sets. Inference is gene-level within the locked list, not list-level enrichment. Published variants in panel genes are inventoried for AD, PD and ASD (35 cited entries in the companion manuscripts); they are context for proposed research constructs, not clinical risk scores.

Related articles

Related articles are currently not available for this article.